Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.
暂无分享,去创建一个
C. Roehrborn | E. Crawford | J. Kusek | Joseph A. Smith | L. Nyberg | K. Slawin | O. Bautista | J. Mcconnell | Shandra S. Wilson | A. Meehan | Michael C Lieber | William R. Noble | J. Smith | S. Wilson | Michael C. Lieber
[1] M. Marberger,et al. Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years. , 2004, Urology.
[2] C. Roehrborn,et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. , 2003, The New England journal of medicine.
[3] C. Roehrborn,et al. Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. , 2002, European urology.
[4] M. Barry,et al. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. , 2002, Urology.
[5] C. Roehrborn,et al. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials. , 2001, Urology.
[6] S. Kaplan,et al. Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia. , 2001, Urology.
[7] M. Marberger,et al. Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention , 2000, European Urology.
[8] P. Boyle,et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. , 1999, Urology.
[9] R. Roberts,et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. , 1999, The Journal of urology.
[10] E. Rimm,et al. Incidence rates and risk factors for acute urinary retention: the health professionals followup study. , 1999, The Journal of urology.
[11] C. Roehrborn,et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. , 1999, Urology.
[12] R. Roberts,et al. Natural history of prostatism: risk factors for acute urinary retention. , 1997, The Journal of urology.
[13] A L Gould,et al. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. , 1996, Urology.
[14] M. Barry,et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? , 1995, The Journal of urology.
[15] C G Chute,et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. , 1995, The Journal of urology.
[16] J. Mcconnell,et al. The pathophysiology of benign prostatic hyperplasia. , 1991, Journal of andrology.
[17] P. Walsh,et al. The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.
[18] B. Djavan,et al. Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia. , 2005, Current opinion in urology.